A risk score for predicting death in COVID-19 in-hospital infection: A Brazilian single-center study

被引:1
|
作者
Campos Vieira, Marcelo Luiz [1 ]
Afonso, Tania Regina [1 ]
Oliveira, Alessandra Joslin [1 ]
Stangenhaus, Carolina [1 ]
Doria Dantas, Juliana Cardoso [1 ]
Arruda Santos, Luiz Otavio [1 ]
Franca, Lucas Arraes [1 ]
Prado, Rogerio Ruscitto [1 ]
Cordovil, Adriana [1 ]
Monaco, Claudia Gianini [1 ]
Lira Filho, Edgar Bezerra [1 ]
Tude Rodrigues, Ana Clara [1 ]
Bacal, Fernando [1 ]
Janot Matos, Gustavo Faissol [1 ]
Antunes, Telma [1 ]
Aranha Camargo, Luis Fernando [1 ]
Fischer, Claudio Henrique [1 ]
Morhy, Samira Saady [1 ]
机构
[1] Hosp Israelita Albert Einstein, Av Albert Einstein 627-701, Sao Paulo, Brazil
关键词
COVID-19; in-hospital patients; mortality; SOCIETY;
D O I
10.1002/jcu.23195
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Background There is a paucity of information about Brazilian COVID-19 in-hospital mortality probability of death combining risk factors. Objective We aimed to correlate COVID-19 Brazilian in-hospital patients' mortality to demographic aspects, biomarkers, tomographic, echocardiographic findings, and clinical events. Methods A prospective study, single tertiary center in Brazil, consecutive patients hospitalized with COVID-19. We analyzed the data from 111 patients from March to August 2020, performed a complete transthoracic echocardiogram, chest thoracic tomographic (CT) studies, collected biomarkers and correlated to in-hospital mortality. Results Mean age of the patients: 67 +/- 17 years old, 65 (58.5%) men, 29 (26%) presented with systemic arterial hypertension, 18 (16%) with diabetes, 11 (9.9%) with chronic obstructive pulmonary disease. There was need for intubation and mechanical ventilation of 48 (43%) patients, death occurred in 21/111 (18.9%) patients. Multiple logistic regression models correlated variables with mortality: age (OR: 1.07; 95% CI 1.02-1.12; p: 0.012; age >74 YO AUC ROC curve: 0.725), intubation need (OR: 23.35; 95% CI 4.39-124.36; p < 0.001), D dimer (OR: 1.39; 95% CI 1.02-1.89; p: 0.036; value >1928.5 ug/L AUC ROC curve: 0.731), C-reactive protein (OR: 1.18; 95% CI 1.05-1.32; p < 0.005; value >29.35 mg/dl AUC ROC curve: 0.836). A risk score was created to predict intrahospital probability of death, by the equation: 3.6 (age >75 YO) + 66 (intubation need) + 28 (C-reactive protein >29) + 2.2 (D dimer >1900). Conclusions A novel and original risk score were developed to predict the probability of death in Covid 19 in-hospital patients concerning combined risk factors.
引用
收藏
页码:604 / 610
页数:7
相关论文
共 50 条
  • [41] Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
    Laurent Chouchana
    Nathanaël Beeker
    Nicolas Garcelon
    Bastien Rance
    Nicolas Paris
    Elisa Salamanca
    Elisabeth Polard
    Anita Burgun
    Jean-Marc Treluyer
    Antoine Neuraz
    Cardiovascular Drugs and Therapy, 2022, 36 : 1255 - 1255
  • [42] The 123 COVID SCORE: A simple and reliable diagnostic tool to predict in-hospital death in COVID-19 patients on hospital admission
    Ostrowska, Malgorzata
    Kasprzak, Michal
    Fabiszak, Tomasz
    Gajda, Jacek
    Jaje-Rykowska, Natalia
    Michalski, Piotr
    Moczulska, Beata
    Nowek, Paulina
    Piasecki, Maciej
    Pilaczynska-Cemel, Marta
    Podhajski, Przemyslaw
    Prudzic, Paulina
    Stepniak, Dominika
    Swiatkowski, Damian
    Zechowicz, Maciej
    Gajda, Robert
    Gromadzinski, Leszek
    Krys, Jacek
    Kubica, Aldona
    Przybylski, Grzegorz
    Szymanski, Pawel
    Kubica, Jacek
    PLOS ONE, 2024, 19 (10):
  • [43] Prognostic utility of cardiovascular indices in COVID-19 infection: A single-center prospective study in India
    Lakhani, Aisha
    Laturkar, Nikhil
    Dhok, Avinash
    Mitra, Kajal
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (10) : 6297 - 6302
  • [44] Impact of diabetes on the severity of COVID-19 infection in pregnant women - A single-center descriptive study
    Kurian, Simi
    Mathews, Manu
    Reshmi, V. P.
    Divakaran, Binoo
    Ajith, S.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (01)
  • [45] Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study
    Duan, Chuanxin
    Zhou, Wangji
    Zhang, Miaoyan
    Cheng, Chongsheng
    Xu, Wenshuai
    Dai, Jinrong
    Meng, Shuzhen
    Chen, Keqi
    Zhao, Yang
    Liu, Song
    Wang, Shao-Ting
    Yang, Yanli
    Xu, Kai-Feng
    Tian, Xinlun
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [46] Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study
    Chuanxin Duan
    Wangji Zhou
    Miaoyan Zhang
    Chongsheng Cheng
    Wenshuai Xu
    Jinrong Dai
    Shuzhen Meng
    Keqi Chen
    Yang Zhao
    Song Liu
    Shao-Ting Wang
    Yanli Yang
    Kai-Feng Xu
    Xinlun Tian
    Orphanet Journal of Rare Diseases, 18
  • [47] Schiavonia Hospital response to COVID-19 outbreak: a first single-center experience
    Marcon, Elena
    Scotton, Francesca
    Marcante, Elena
    Rigo, Alberto
    Monticelli, Jacopo
    Buggio, Maria Emanuela
    Pilerci, Claudio
    Montemurro, Domenico
    Benini, Patrizia
    ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2020, 56 (03): : 365 - 372
  • [48] COVID-19 infection risk in patients on immunosuppressive/immunomodulator therapy: A single center study
    Ghiasi, Maryam
    Nasimi, Maryam
    Ghandi, Narges
    Lajevardi, Vahideh
    Abedini, Robabeh
    Azizpour, Arghavan
    Ansari, Mahshid Sadat
    Kheiltash, Azita
    Balighi, Kamran
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [49] A Clinical Risk Score to Predict In-hospital Mortality from COVID-19 in South Korea
    Her, Ae-Young
    Bhak, Youngjune
    Jun, Eun Jung
    Yuan, Song Lin
    Garg, Scot
    Lee, Semin
    Bhak, Jong
    Shin, Eun-Seok
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (15) : e108
  • [50] Covid-19 Infection in Children with Cancer: Single-Center Experience from Turkey
    Eker, N.
    Tokuc, A. G.
    Tufan, B.
    Aras, S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S442 - S442